COMMUNIQUÉS West-GlobeNewswire

Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
05/05/2026
- Planning for dual launches of bezuclastinib in Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST) - Pivotal data from Phase 3 PEAK trial in GIST patients selected for oral presentation at 2026 ASCO [...]
Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
05/05/2026
Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screened Previous open label trial data presented at SIRS 2026 showed no safety or drug–drug interaction [...]
Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.
05/05/2026
SARASOTA, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, [...]
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
05/05/2026
-- Integrated sperm preparation and intratubal insemination drive earlier intervention and streamlined, in-office care within routine OB/GYN practice -- ATLANTA, May 05, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: [...]
Noom Names “Power of Habit” Author Charles Duhigg as Advisor, Releases New Research Linking GLP-1 Success to Habit Formation
05/05/2026
First-of-its-kind Noom Psychosocial GLP-1 Report finds more than 90% of GLP-1 users say medication helped them adopt healthier habits, with reported benefits extending beyond weight to quality of life, joy, and [...]
FEATOL Introduces Back Brace Support Belt for Everyday Lower Back Support
05/05/2026
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Lower back pain is becoming increasingly common in daily life, with more than one in four U.S. adults reporting ongoing discomfort. As more people look for ways to stay active [...]
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025
05/05/2026
Overall, studies show: OGM Can Resolve Previously Unresolved Rare Disease Cases OGM Can Serve as a Gold Standard Technique for Characterization of SVs OGM Can Complement Sequencing for Better SV Sensitivity and Genomic [...]
Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program
05/05/2026
Order supports customer’s full launch, with shipments expected to commence shortly and be fulfilled over 12 -15 months LITTLETON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI [...]
Health Canada Authorizes North America’s First Hepatitis B Rapid Test, bioLytical’s iStatis Hepatitis B Surface Antigen Test
05/05/2026
bioLytical’s iStatis test delivers results in 15 minutes in clinical and community settings A Critical Step in Hepatitis B Diagnosis and Prevention in Canada bioLytical’s iStatis Hepatitis Surface Antigen Test (iStatis [...]
Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab
05/05/2026
- Abstract from trial evaluating Alpha DaRT ® in combination with pembrolizumab in elderly patients with locally advanced and metastatic head and neck squamous cell carcinoma selected for podium presentation - - The [...]
SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System
05/05/2026
FORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII) , a developer of innovative surgical robotic technologies dedicated to making [...]
SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets
05/05/2026
RANCHO CORDOVA, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- SK pharmteco announced today that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative ( [...]
CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026
05/05/2026
PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the first quarter ended March 31, 2026, before the market opens on [...]
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
05/05/2026
Data demonstrate colon tissue PDE4/cAMP pathway modulation and sustained active metabolite exposure above IC90 across the dosing interval Steady-state pharmacokinetic findings provide mechanistic support for previously [...]
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
05/05/2026
Completed enrollment of the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP); topline data expected in Q4 2026 Updated data from Phase 2 study of DISC-0974 in patients with anemia of [...]
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
05/05/2026
CINCINNATI, May 05, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2026 Health Care Conference on Tuesday, May 12, 2026, at 3 [...]
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
05/05/2026
Vancouver, Canada, May 05, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non- [...]
Clene Announces $7 Million Underwritten Offering of Common Stock
05/05/2026
SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene” or the “Company”) and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late clinical-stage [...]
MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI
05/05/2026
VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company commercializing AI-driven [...]

Pages